FDA Alerts

FDA Alerts
FDA Alerts
FDA Approves Adalimumab Biosimilar
09/26/2016
The FDA approved the biosimilar adalimumab-atto for the treatment of inflammatory diseases including RA, psoriatic arthritis, and Crohn's disease.
09/26/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (INVOKAMET XR)
09/21/2016
The FDA has approved INVOKAMET XR for use as a supplement to diet and exercise for improved control of blood glucose levels in adults with type 2 diabetes.
09/21/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Secondary CV Prevention
09/15/2016
The FDA approved Yosprala to treat patients who need aspirin for secondary prevention of cardiovascular and cerebrovascular events.
09/15/2016
Medication Prescribing
Medication Prescribing
FDA Issues Strong Warnings Against Combining Opioids and Benzodiazepine
09/01/2016
The FDA is requiring boxed warnings for opioid analgesics and prescription opioid cough products related to combined use of certain opioids with benzodiazepines.
09/01/2016
FDA Alerts
FDA Alerts
FDA Approves Biosimilar for Various Inflammatory Diseases
08/31/2016
The FDA approved a biosimilar to treat RA, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.
08/31/2016
FDA Alerts
FDA Alerts
FDA Approves New Quadrivalent Influenza Vaccine
08/30/2016
The FDA has approved Afluria Quadrivalent for the use in individuals 18 years and older for active immunization against influenza cause by influenza A and B viruses.
08/30/2016
Infectious Diseases
Infectious Diseases
FDA: Screen All Blood Donations for Zika Virus
08/29/2016
The FDA has issued a revision to their February 2016 guidance for the screening of whole blood and blood components for Zika virus.
08/29/2016
FDA
FDA
FDA Approves Injection for Treating Pediatric Lower Limb Spasticity
08/01/2016
The approval was based on results from a randomized, double-blind, prospective Phase 3 study of 235 pediatric patients.
08/01/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Type 2 Diabetes (lixisenatide)
07/29/2016
The FDA has approved lixisenatide as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
07/29/2016
FDA Alerts
FDA Alerts
FDA enhances warnings on fluoroquinolones
07/27/2016
By Reuters Staff
07/27/2016